Mutational Analysis of Glycogen Synthase Kinase 3β Protein Kinase Together with Kinome-Wide Binding and Stability Studies Suggests Context-Dependent Recognition of Kinases by the Chaperone Heat Shock Protein 90
暂无分享,去创建一个
T. Pawson | M. Bantscheff | J. Woodgett | M. Savitski | A. Pasculescu | K. Colwill | L. Taylor | Jing Jin | A. Dai | Kelly Williton | Ruijun Tian
[1] T. Pawson,et al. Integrative analysis of kinase networks in TRAIL-induced apoptosis provides a source of potential targets for combination therapy , 2015, Science Signaling.
[2] A. Gingras,et al. Combinatorial proteomic analysis of intercellular signaling applied to the CD28 T-cell costimulatory receptor , 2015, Proceedings of the National Academy of Sciences.
[3] S. Rüdiger,et al. Hsp90 interaction with clients. , 2015, Trends in biochemical sciences.
[4] M. Sherman,et al. Hsp70 in cancer: back to the future , 2014, Oncogene.
[5] Bonnie Berger,et al. A Quantitative Chaperone Interaction Network Reveals the Architecture of Cellular Protein Homeostasis Pathways , 2014, Cell.
[6] Tony Pawson,et al. CoreFlow: a computational platform for integration, analysis and modeling of complex biological data. , 2014, Journal of proteomics.
[7] D. Proia,et al. Ganetespib and HSP90: translating preclinical hypotheses into clinical promise. , 2014, Cancer research.
[8] L. Neckers,et al. Stressing the Development of Small Molecules Targeting HSP90 , 2013, Clinical Cancer Research.
[9] L. Paz-Ares,et al. Inhibition of HSP90 molecular chaperones: moving into the clinic. , 2013, The Lancet. Oncology.
[10] Paul Workman,et al. ATP-competitive inhibitors block protein kinase recruitment to the Hsp90-Cdc37 system. , 2013, Nature chemical biology.
[11] D. Agard,et al. Uncovering a region of heat shock protein 90 important for client binding in E. coli and chaperone function in yeast. , 2013, Molecular cell.
[12] Susan Lindquist,et al. Quantitative Analysis of Hsp90-Client Interactions Reveals Principles of Substrate Recognition , 2012, Cell.
[13] Jian Jin,et al. Dynamic Reprogramming of the Kinome in Response to Targeted MEK Inhibition in Triple-Negative Breast Cancer , 2012, Cell.
[14] Bernhard Kuster,et al. Systematic Identification of the HSP90 Regulated Proteome , 2012, Molecular & Cellular Proteomics.
[15] G. Drewes,et al. Hsp90 inhibition differentially destabilises MAP kinase and TGF-beta signalling components in cancer cells revealed by kinase-targeted chemoproteomics , 2012, BMC Cancer.
[16] S. Larson,et al. Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90. , 2011, Nature chemical biology.
[17] Pablo C. Echeverría,et al. An Interaction Network Predicted from Public Data as a Discovery Tool: Application to the Hsp90 Molecular Chaperone Machine , 2011, PloS one.
[18] D. Bolon,et al. Hsp90 and client protein maturation. , 2011, Methods in molecular biology.
[19] L. Regan,et al. Balance between folding and degradation for Hsp90-dependent client proteins: a key role for CHIP. , 2010, Biochemistry.
[20] G. Giaccone,et al. Update on Hsp90 inhibitors in clinical trial. , 2009, Current topics in medicinal chemistry.
[21] M. Mann,et al. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification , 2008, Nature Biotechnology.
[22] D. Sternberg,et al. Akt shows variable sensitivity to an Hsp90 inhibitor depending on cell context. , 2007, Experimental cell research.
[23] Bernhard Kuster,et al. Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors , 2007, Nature Biotechnology.
[24] A. K. Mandal,et al. Molecular chaperones and protein kinase quality control. , 2007, Trends in cell biology.
[25] P. Lochhead,et al. A chaperone-dependent GSK3beta transitional intermediate mediates activation-loop autophosphorylation. , 2006, Molecular cell.
[26] L. Neckers. Using natural product inhibitors to validate Hsp90 as a molecular target in cancer. , 2006, Current topics in medicinal chemistry.
[27] S. Pietrokovski,et al. Hsp90 Recognizes a Common Surface on Client Kinases* , 2006, Journal of Biological Chemistry.
[28] Laurence H Pearl,et al. Hsp90 and Cdc37 -- a chaperone cancer conspiracy. , 2005, Current opinion in genetics & development.
[29] Zhexin Xiang,et al. Surface charge and hydrophobicity determine ErbB2 binding to the Hsp90 chaperone complex , 2005, Nature Structural &Molecular Biology.
[30] T. Pawson,et al. Proteomic, Functional, and Domain-Based Analysis of In Vivo 14-3-3 Binding Proteins Involved in Cytoskeletal Regulation and Cellular Organization , 2004, Current Biology.
[31] R. Matts,et al. Phosphorylation of Serine 13 Is Required for the Proper Function of the Hsp90 Co-chaperone, Cdc37* , 2003, Journal of Biological Chemistry.
[32] B. Doble,et al. GSK-3: tricks of the trade for a multi-tasking kinase , 2003, Journal of Cell Science.
[33] Laurence H. Pearl,et al. Crystal Structure of Glycogen Synthase Kinase 3β Structural Basis for Phosphate-Primed Substrate Specificity and Autoinhibition , 2001, Cell.
[34] P. Cohen,et al. A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation. , 2001, Molecular Cell.
[35] T. Fleming,et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. , 2001, The New England journal of medicine.
[36] Y. Yarden,et al. Sensitivity of Mature ErbB2 to Geldanamycin Is Conferred by Its Kinase Domain and Is Mediated by the Chaperone Protein Hsp90* , 2001, The Journal of Biological Chemistry.
[37] T. Tsuruo,et al. Modulation of Akt kinase activity by binding to Hsp90. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[38] I. Benjamin,et al. Induction of a heat shock factor 1-dependent stress response alters the cytotoxic activity of hsp90-binding agents. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[39] J. Woodgett,et al. Modulation of the glycogen synthase kinase‐3 family by tyrosine phosphorylation. , 1993, The EMBO journal.
[40] H. Wiley,et al. Mutational removal of the Thr669 and Ser671 phosphorylation sites alters substrate specificity and ligand-induced internalization of the epidermal growth factor receptor. , 1990, The Journal of biological chemistry.